The relative merits of prostigmin and mestinon in the treatment of myasthenia gravis.
D009157:Myasthenia Gravis / Q000628:therapy*; D009388:Neostigmine / Q000627:therapeutic use*; D010277:Parasympathomimetics / Q000627:therapeutic use*; D011729:Pyridostigmine Bromide
D010277:Parasympathomimetics; D009388:Neostigmine; D011729:Pyridostigmine Bromide
MYASTHENIA GRAVIS/therapy; NEOSTIGMINE/therapeutic use; PARASYMPATHOMIMETICS/therapeutic use